Antibiotic pharmacokinetic and pharmacodynamic considerations in critical illness.
about
Optimizing antimicrobial therapy in critically ill patientsRelevance of Liver Failure for Anti-Infective Agents: From Pharmacokinetic Alterations to Dosage AdjustmentsReducing medication errors in critical care: a multimodal approach.Tobramycin disposition in ICU patients receiving a once daily regimen: population approach and dosage simulations.Population pharmacokinetics of imipenem in critically ill patients with suspected ventilator-associated pneumonia and evaluation of dosage regimensAntibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams.Treatment of Pseudomonas aeruginosa infection in critically ill patients.Amikacin population pharmacokinetics in critically ill Kuwaiti patients.Dosing of antimicrobial agents in critically-ill patients with acute kindey injury and continuous venvenous haemofiltration.Protein binding of antimicrobials: methods for quantification and for investigation of its impact on bacterial killing.Drug absorption, distribution, metabolism and excretion considerations in critically ill adults.Approaches for dosage individualisation in critically ill patients.Role of an electronic antimicrobial alert system in intensive care in dosing errors and pharmacist workload.Pharmacokinetic considerations for drugs administered in the critically ill.Simultaneous determination of 12 beta-lactam antibiotics in human plasma by high-performance liquid chromatography with UV detection: application to therapeutic drug monitoring.Amikacin in Critically Ill Patients: A Review of Population Pharmacokinetic Studies.Impact of imipenem and amikacin pharmacokinetic/pharmacodynamic parameters on microbiological outcome of Gram-negative bacilli ventilator-associated pneumonia.Management of aminoglycosides in the intensive care unit.Effect of treatment duration on pharmacokinetic/pharmacodynamic indices correlating with therapeutic efficacy of ceftazidime in experimental Klebsiella pneumoniae lung infection.Pharmacokinetics of colistin in critically ill patients with multidrug-resistant Gram-negative bacilli infection.Closed-Loop- and Decision-Assist-Guided Fluid Therapy of Human Hemorrhage.Population Pharmacokinetic Model to Optimize Cefotaxime Dosing Regimen in Critically Ill Children.Phenobarbital in intensive care unit pediatric population: predictive performances of population pharmacokinetic model.
P2860
Q26999905-AC915E23-E234-42FA-B3B8-39274F3A63BAQ33763177-2CA8C38C-79FF-4C33-937D-623F6C4AA73EQ34140686-6BA2951A-70B8-4489-8517-3C502E8AEAF3Q34476089-1E2EE0FD-D86C-41A7-8A02-76B14635D50BQ34570886-E0DC5026-EBB9-459F-B7B7-8C5141BD8B52Q35908084-8F56C017-6661-4DD0-A79B-AA7D32497DF7Q36607415-B26B0D21-856E-46B1-AEB2-2B8A27A80261Q36635220-941087A8-3947-4BE2-A836-2AF71E8ED688Q37088305-F3C511B7-BBE1-4F29-B053-D12F3DE96891Q37149078-3FE40B45-D7DF-4E1A-A2AC-7DB423FFB7C7Q38107537-C0F454A8-ACEF-4BA1-BC2E-1A56240BFFD4Q38125209-E9BF6BED-DDED-42DE-98D2-5A07FC9FE09DQ38350109-9C477CC8-9C2C-484D-8BA4-91749DC3B6F3Q38351793-C7B14368-8DE7-4867-8F39-1988C5173C3CQ38627385-214E1386-0CD7-4EE0-82FA-7B0633C6A4FBQ38850670-7FCEB74C-DE5F-4F25-8052-B7961E117E0FQ41516734-FB2D6855-AF0B-44C6-BE79-E0D26A5C674FQ42908869-7FDE4105-99EA-44C1-B21D-D77BA8A8945EQ43152276-4245FC03-AEF6-4105-8D6E-C643EA6EC1C9Q44481718-D4B40C61-7284-45F7-AB5F-A8C149B1243DQ47775499-5721E9BE-E3DF-4F6B-84D7-99528AF08978Q47861094-3F9BA72A-CF1B-414D-A511-FE8D129CFAF4Q48277347-D3E13966-F805-4041-984C-58435001F252
P2860
Antibiotic pharmacokinetic and pharmacodynamic considerations in critical illness.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Antibiotic pharmacokinetic and pharmacodynamic considerations in critical illness.
@ast
Antibiotic pharmacokinetic and pharmacodynamic considerations in critical illness.
@en
type
label
Antibiotic pharmacokinetic and pharmacodynamic considerations in critical illness.
@ast
Antibiotic pharmacokinetic and pharmacodynamic considerations in critical illness.
@en
prefLabel
Antibiotic pharmacokinetic and pharmacodynamic considerations in critical illness.
@ast
Antibiotic pharmacokinetic and pharmacodynamic considerations in critical illness.
@en
P2093
P2860
P1476
Antibiotic pharmacokinetic and pharmacodynamic considerations in critical illness.
@en
P2093
Mark Palazzo
Raffaele De Gaudio
Rina Mehrotra
P2860
P2888
P304
P356
10.1007/S00134-004-2428-9
P577
2004-11-05T00:00:00Z